Ziconotide Combination Intrathecal Therapy for Noncancer Pain Is Limited Secondary to Delayed Adverse Effects: A Case Series With a 24-Month Follow-Up. [electronic resource]
- Neuromodulation : journal of the International Neuromodulation Society Jul 2015
- 397-403 p. digital